SLC7A11 and inflammatory bowel disease: Riluzole, an SLC7A11 inhibitor used to manage ALS (Amyotrophic lateral sclerosis), and sulfasalazine, which is used to treat IBD (inflammatory bowel disease) and arthritis were also identified as potential candidates.